Roxithromycin

• 产品号: Roxithromycin
• CAS号: 80214-83-1
• 分子式: C41H76N2O15
• 分子量: 837.04654

产品别名

• 标题: Roxithromycin
• IUPAC标准名: (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-10-(2,4,7-trioxa-1-azaoctan-1-ylidene)-1-oxacyclotetradecan-2-one
• IUPAC传统名: roxiβ

产品登记号

• CHEBI ID: 48935
• CHEMBL: 1214185
• DrugBank ID: DB00778
• 美国药典/FDA物质标识码: 21KOF230FA
• 维基百科标题: Roxithromycin
• ATC码: J01FA06
• KEGG ID: D01710
• CAS号: 80214-83-1
• PubChem CID: 6915744
• Chemspider ID: 5291557

产品性质

• 半衰期: 11 hours
• 代谢: Liver, peak concentration averaging 2 hours after ingestion.
• 妊娠期药物分类: ? (USA) ; B1 (Aus)